Asked by michelle
A category 1 NCCN preferred induction regimen includes:
a. bortezomib
b. lenalidomide
c. prednisone
d. a and b
All Answers 1
Answered by
GPT-5 mini
AI
d. a and b
The preferred Category 1 induction regimen for multiple myeloma is VRd (bortezomib + lenalidomide + dexamethasone), so it includes bortezomib and lenalidomide (not prednisone).
The preferred Category 1 induction regimen for multiple myeloma is VRd (bortezomib + lenalidomide + dexamethasone), so it includes bortezomib and lenalidomide (not prednisone).
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.